Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment

Precision medicine in oncology seeks to individualize each patient’s treatment regimen based on an accurate assessment of the risk of recurrence or progression of that person’s cancer. Precision will be achieved at each phase of care, from detection to diagnosis to surgery, systemic therapy, and rad...

Full description

Bibliographic Details
Main Author: Eleanor E. R. Harris
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2018/4809183
id doaj-5609b9af9d394f75b62e3058fd4e82ed
record_format Article
spelling doaj-5609b9af9d394f75b62e3058fd4e82ed2020-11-25T00:15:18ZengHindawi LimitedInternational Journal of Breast Cancer2090-31702090-31892018-01-01201810.1155/2018/48091834809183Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and TreatmentEleanor E. R. Harris0Department of Radiation Oncology, Case Western Reserve University and University Hospitals, Cleveland, OH, USAPrecision medicine in oncology seeks to individualize each patient’s treatment regimen based on an accurate assessment of the risk of recurrence or progression of that person’s cancer. Precision will be achieved at each phase of care, from detection to diagnosis to surgery, systemic therapy, and radiation therapy, to survivorship and follow-up care. The precision arises from detailed knowledge of the inherent biological propensities of each tumor, rather than generalizing treatment approaches based on phenotypic, or even genotypic, categories. Extensive research is being conducted in multiple disciplines, including radiology, pathology, molecular biology, and surgical, medical, and radiation oncology. Clinical trial design is adapting to the new paradigms and moving away from grouping heterogeneous patient populations into limited treatment comparison arms. This review touches on several areas invested in clinical research. This special issue highlights the specific work of a number of groups working on precision medicine for breast cancer.http://dx.doi.org/10.1155/2018/4809183
collection DOAJ
language English
format Article
sources DOAJ
author Eleanor E. R. Harris
spellingShingle Eleanor E. R. Harris
Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment
International Journal of Breast Cancer
author_facet Eleanor E. R. Harris
author_sort Eleanor E. R. Harris
title Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment
title_short Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment
title_full Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment
title_fullStr Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment
title_full_unstemmed Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment
title_sort precision medicine for breast cancer: the paths to truly individualized diagnosis and treatment
publisher Hindawi Limited
series International Journal of Breast Cancer
issn 2090-3170
2090-3189
publishDate 2018-01-01
description Precision medicine in oncology seeks to individualize each patient’s treatment regimen based on an accurate assessment of the risk of recurrence or progression of that person’s cancer. Precision will be achieved at each phase of care, from detection to diagnosis to surgery, systemic therapy, and radiation therapy, to survivorship and follow-up care. The precision arises from detailed knowledge of the inherent biological propensities of each tumor, rather than generalizing treatment approaches based on phenotypic, or even genotypic, categories. Extensive research is being conducted in multiple disciplines, including radiology, pathology, molecular biology, and surgical, medical, and radiation oncology. Clinical trial design is adapting to the new paradigms and moving away from grouping heterogeneous patient populations into limited treatment comparison arms. This review touches on several areas invested in clinical research. This special issue highlights the specific work of a number of groups working on precision medicine for breast cancer.
url http://dx.doi.org/10.1155/2018/4809183
work_keys_str_mv AT eleanorerharris precisionmedicineforbreastcancerthepathstotrulyindividualizeddiagnosisandtreatment
_version_ 1725387711460671488